← Back to headlines
Celldex Presents Barzolvolimab Data at Cantor Conference
Biotech company Celldex presented new clinical data for barzolvolimab at the Cantor conference, highlighting potential developments in its oncology pipeline.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Elon Musk Condemns New Documentary as 'Hit Piece' and Threatens Legal Action
43m ago
UAE Announces $46 Billion Investment Plan to Strengthen Economic Ties with Germany
45m ago
TTM Technologies Prices $500 Million Senior Notes
1h ago
Adobe Beats Q3 Revenue Estimates Despite Wall Street Demand for More AI Growth
1h ago